• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Caribou Biosciences, Inc. - Common Stock (NQ:CRBU)

    1.560 UNCHANGED
    Streaming Delayed Price Updated: 4:15 PM EST, Jan 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 125
    Open 1.560
    Bid (Size) 1.560 (6,600)
    Ask (Size) 1.610 (100)
    Prev. Close 1.560
    Today's Range 1.560 - 1.560
    52wk Range 0.6600 - 3.535
    Shares Outstanding 60,705,391
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
    Issued on behalf of GT Biopharma, Inc. 
    From Equity Insider
    Via GlobeNewswire
    News headline image
    Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025
    From Caribou Biosciences, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -1.9%
    -1.9%
    1 Month
    -7.7%
    -7.7%
    3 Month
    -41.6%
    -41.6%
    6 Month
    -14.8%
    -14.8%
    1 Year
    -0.6%
    -0.6%

    More News

    Read More
    Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments ↗
    Via Stocktwits
    News headline image
    Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Caribou Biosciences to Participate in Upcoming Investor Conferences
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Aprea Therapeutics (Nasdaq: APRE) Transforms Cutting-Edge Science into Next-Generation Cancer Therapies – More Stocks Inside
    Via AB Newswire
    Topics Artificial Intelligence
    News headline image
    Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today? ↗
    Via Benzinga
    News headline image
    Gapping stocks in Monday's session ↗
    Via Chartmill
    News headline image
    Discover the top movers in Monday's pre-market session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
    Via MarketMinute
    Topics Artificial Intelligence Climate Change Economy
    News headline image
    Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Caribou Biosciences Inc (NASDAQ:CRBU) Posts Mixed Q2 2025 Earnings with Revenue Beat but Wider Loss ↗
    Via Chartmill
    News headline image
    Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering ↗
    Via Benzinga
    News headline image
    Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs
    From Caribou Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
    From Caribou Biosciences, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Caribou Biosciences, Inc. - Common Stock publicly traded?
    Yes, Caribou Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Caribou Biosciences, Inc. - Common Stock trade on?
    Caribou Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Caribou Biosciences, Inc. - Common Stock?
    The ticker symbol for Caribou Biosciences, Inc. - Common Stock is CRBU on the Nasdaq Stock Market
    What is the current price of Caribou Biosciences, Inc. - Common Stock?
    The current price of Caribou Biosciences, Inc. - Common Stock is 1.560
    When was Caribou Biosciences, Inc. - Common Stock last traded?
    The last trade of Caribou Biosciences, Inc. - Common Stock was at 01/15/26 04:15 PM ET
    What is the market capitalization of Caribou Biosciences, Inc. - Common Stock?
    The market capitalization of Caribou Biosciences, Inc. - Common Stock is 94.70M
    How many shares of Caribou Biosciences, Inc. - Common Stock are outstanding?
    Caribou Biosciences, Inc. - Common Stock has 95M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.